Safety and Efficacy of Repeat Use of Picato 0.05% in the Treatment of Anogenital Warts
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Warts
- Focus Adverse reactions
- Sponsors LEO Pharma
- 03 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Nov 2015 Planned end date changed from 1 Oct 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
- 13 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.